400 related articles for article (PubMed ID: 15634933)
1. TNF receptor-associated factor 6 is an essential mediator of CD40-activated proinflammatory pathways in monocytes and macrophages.
Mukundan L; Bishop GA; Head KZ; Zhang L; Wahl LM; Suttles J
J Immunol; 2005 Jan; 174(2):1081-90. PubMed ID: 15634933
[TBL] [Abstract][Full Text] [Related]
2. CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptor-associated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways.
Pearson LL; Castle BE; Kehry MR
Int Immunol; 2001 Mar; 13(3):273-83. PubMed ID: 11222496
[TBL] [Abstract][Full Text] [Related]
3. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
[TBL] [Abstract][Full Text] [Related]
4. Competition between TRAF2 and TRAF6 regulates NF-kappaB activation in human B lymphocytes.
Zhang W; Zhang X; Wu XL; He LS; Zeng XF; Crammer AC; Lipsky PE
Chin Med Sci J; 2010 Mar; 25(1):1-12. PubMed ID: 20449947
[TBL] [Abstract][Full Text] [Related]
5. A novel mechanism for TNFR-associated factor 6-dependent CD40 signaling.
Rowland SL; Tremblay MM; Ellison JM; Stunz LL; Bishop GA; Hostager BS
J Immunol; 2007 Oct; 179(7):4645-53. PubMed ID: 17878362
[TBL] [Abstract][Full Text] [Related]
6. Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile.
Lutgens E; Lievens D; Beckers L; Wijnands E; Soehnlein O; Zernecke A; Seijkens T; Engel D; Cleutjens J; Keller AM; Naik SH; Boon L; Oufella HA; Mallat Z; Ahonen CL; Noelle RJ; de Winther MP; Daemen MJ; Biessen EA; Weber C
J Exp Med; 2010 Feb; 207(2):391-404. PubMed ID: 20100871
[TBL] [Abstract][Full Text] [Related]
7. Cellular responses to murine CD40 in a mouse B cell line may be TRAF dependent or independent.
Manning E; Pullen SS; Souza DJ; Kehry M; Noelle RJ
Eur J Immunol; 2002 Jan; 32(1):39-49. PubMed ID: 11754002
[TBL] [Abstract][Full Text] [Related]
8. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs.
Pullen SS; Dang TT; Crute JJ; Kehry MR
J Biol Chem; 1999 May; 274(20):14246-54. PubMed ID: 10318845
[TBL] [Abstract][Full Text] [Related]
9. CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells.
Schwabe RF; Schnabl B; Kweon YO; Brenner DA
J Immunol; 2001 Jun; 166(11):6812-9. PubMed ID: 11359840
[TBL] [Abstract][Full Text] [Related]
10. CD40 signaling of monocyte inflammatory cytokine synthesis through an ERK1/2-dependent pathway. A target of interleukin (il)-4 and il-10 anti-inflammatory action.
Suttles J; Milhorn DM; Miller RW; Poe JC; Wahl LM; Stout RD
J Biol Chem; 1999 Feb; 274(9):5835-42. PubMed ID: 10026206
[TBL] [Abstract][Full Text] [Related]
11. Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40.
Tsukamoto N; Kobayashi N; Azuma S; Yamamoto T; Inoue J
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1234-9. PubMed ID: 9990007
[TBL] [Abstract][Full Text] [Related]
12. TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation.
Pype S; Declercq W; Ibrahimi A; Michiels C; Van Rietschoten JG; Dewulf N; de Boer M; Vandenabeele P; Huylebroeck D; Remacle JE
J Biol Chem; 2000 Jun; 275(24):18586-93. PubMed ID: 10764746
[TBL] [Abstract][Full Text] [Related]
13. Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages.
Park DR; Thomsen AR; Frevert CW; Pham U; Skerrett SJ; Kiener PA; Liles WC
J Immunol; 2003 Jun; 170(12):6209-16. PubMed ID: 12794152
[TBL] [Abstract][Full Text] [Related]
14. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor receptor-associated factor 6 (TRAF6) stimulates extracellular signal-regulated kinase (ERK) activity in CD40 signaling along a ras-independent pathway.
Kashiwada M; Shirakata Y; Inoue JI; Nakano H; Okazaki K; Okumura K; Yamamoto T; Nagaoka H; Takemori T
J Exp Med; 1998 Jan; 187(2):237-44. PubMed ID: 9432981
[TBL] [Abstract][Full Text] [Related]
16. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
Hauer J; Püschner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970
[TBL] [Abstract][Full Text] [Related]
17. Blockade of CD40-TRAF2,3 or CD40-TRAF6 is sufficient to inhibit pro-inflammatory responses in non-haematopoietic cells.
Portillo JA; Greene JA; Schwartz I; Subauste MC; Subauste CS
Immunology; 2015 Jan; 144(1):21-33. PubMed ID: 25051892
[TBL] [Abstract][Full Text] [Related]
18. Suppressor of cytokine signaling 1 inhibits cytokine induction of CD40 expression in macrophages.
Wesemann DR; Dong Y; O'Keefe GM; Nguyen VT; Benveniste EN
J Immunol; 2002 Sep; 169(5):2354-60. PubMed ID: 12193701
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages.
Loniewski KJ; Patial S; Parameswaran N
Mol Immunol; 2007 Jul; 44(15):3715-23. PubMed ID: 17507094
[TBL] [Abstract][Full Text] [Related]
20. An 11-amino acid sequence in the cytoplasmic domain of CD40 is sufficient for activation of c-Jun N-terminal kinase, activation of MAPKAP kinase-2, phosphorylation of I kappa B alpha, and protection of WEHI-231 cells from anti-IgM-induced growth arrest.
Sutherland CL; Krebs DL; Gold MR
J Immunol; 1999 Apr; 162(8):4720-30. PubMed ID: 10202013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]